Skip to content
A split frame: on the left a smiling woman with glasses seated in an armchair with a small device strapped to her chest, on the right a man in a cap smiling behind a closed laptop on a table.

Cyborgs

FDA lets Paradromics recruit brain-implant study participants across the United States

Image: Paradromics / YouTube · video-thumbnail

Published · North America

Paradromics said on 26 October 2026 that the FDA approved a change to its Connect-One study, removing the rule that participants live within four hours of a site.

Paradromics announced on 26 October 2026 that the U.S. Food and Drug Administration approved an amendment to the protocol of Connect-One, the early feasibility study of its Connexus brain-computer interface. The change removes the requirement that candidates live within a four-hour drive of a study site, opening recruitment across the continental United States.

The study runs at UC Davis Health, Mass General Brigham and University of Michigan Health. The FDA first authorized it in November 2025, and the first long-term implantation was completed at University of Michigan Health in June 2026. Paradromics says that first participant is now using the device to communicate.

The company gave no enrolment target and no count of participants implanted so far, and the arrangements for people travelling long distances still have to be set with the sites and their review boards. The device remains investigational. Distance from a trial site had limited who could take part; the amendment widens the pool of people with paralysis who can apply.

Sources

On RobotShop

Biometric Sensors